Crinecerfont is the first new treatment in 70 years for classic CAH and the only one that directly reduces excess ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first presentation of data from ...

Merck & Co. has shown off data on its ROR1-directed antibody-drug conjugate, trumpeting a 100% complete response rate but ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

Analysts called the data “very competitive” but raised questions about safety. Merck gained ownership of the ADC when it ...

Arrowhead (ARWR) announced interim results from a Phase 1/2a clinical study of ARO-CFB, the company’s investigational RNA interference, or ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

This medication can be found in doses of 50, 100, and 200 mg, but Hims prescribes only 100-mg pills priced at $53 each. Stendra is another PDE5 inhibitor and is a worthwhile alternative for people ...

Filgotinib, a JAK1 preferential inhibitor, shows promise as an effective and well-tolerated maintenance therapy for Crohn's ...

The latest data from a new CDC report show a 700% plus increase in overdose deaths involving the fentanyl analog carfentanil ...

Fluvoxamine belongs to a group of medicines known as selective serotonin reuptake inhibitors (SSRIs) and is used to treat ...

AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out ...